Key facts
- It is a maintenance treatment for COPD and should not be used to treat a sudden attack of breathlessness or wheezing.
- The usual dose is one inhalation twice a day, in the morning and evening, every day and not only when you have symptoms.
- Stop using it and get medical help straight away if you get tightness of the chest, coughing, wheezing or breathlessness immediately after using it, or signs of an allergic reaction.
- It is not for use in children or adolescents under 18 years.
- Use the inhaler within 90 days of opening the pouch.
Who should not take aclidinium
The leaflet says not to take it if any of these apply to you.
- If you are allergic to aclidinium bromide or any of the other ingredients of this medicine
Check with a doctor or pharmacist first
Tell them before you take it if any of these apply to you.
- If you have had heart problems recently
- If you see halos around lights or coloured images (glaucoma)
- If you have an enlarged prostate, problems passing urine, or a blockage in your bladder
- It is for maintenance treatment and should not be used to treat a sudden attack of breathlessness or wheezing
- If your COPD symptoms (breathlessness, wheezing, cough) do not improve or get worse, contact your doctor as soon as possible
- Dry mouth may be linked to tooth decay after long-term use, so pay attention to oral hygiene
How to take aclidinium
- The recommended dose is one inhalation twice a day, in the morning and evening, ideally at the same times each day.
- Use it every day, not only when you have breathing problems; it is for long-term use, so talk to your doctor before stopping.
- It is inhaled using the Genuair inhaler; follow the Instructions for Use and ask your doctor or pharmacist if unsure. You can use it before or after food or drink.
- If you forget a dose, inhale it as soon as you remember, but skip it if it is nearly time for the next one. Do not take a double dose.
Side effects
Get medical help straight away
The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.
- Allergic reactions (rare): swelling of your face, throat, lips or tongue (with or without difficulty breathing or swallowing), dizziness or fainting, faster heart rate, or raised severely itchy bumps on your skin (hives). Stop using the medicine and contact your doctor immediately
- Bronchospasm: tightness of the chest, coughing, wheezing or breathlessness immediately after using the medicine. Stop taking Eklira Genuair and seek medical help immediately (frequency not stated)
How common each side effect is
Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.
Common
Up to 1 in 10 people
- Headache
- Inflammation of the sinuses (sinusitis)
- Common cold (nasopharyngitis)
- Cough
- Diarrhoea
- Nausea
Uncommon
Up to 1 in 100 people
- Dizziness
- Dry mouth
- Inflammation of the mouth (stomatitis)
- Hoarseness (dysphonia)
- Faster heart beat (tachycardia)
- Sensation of heart beating (palpitations)
- Difficulty passing urine (urinary retention)
- Blurred vision
- Rash
- Itching of the skin
Rare
Up to 1 in 1,000 people
- Allergic reactions
If you get a side effect, you can report it to the regulator through the Yellow Card scheme.
Pregnancy and breastfeeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning a baby, ask your doctor or pharmacist for advice before using this medicine. You should not use it while pregnant or breast-feeding unless your doctor tells you to.
Taking it with other medicines
The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.
- Any other medicines you are taking, have recently taken or might take
- Similar medicines for breathing problems, such as medicines containing tiotropium or ipratropium (use together with Eklira Genuair is not recommended)
Where this comes from
Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.
- Product
- Eklira Genuair 322 micrograms Inhalation Powder
- Product licence
- PLPI568300161
- Leaflet dated
- Checked against the leaflet
- Automated check
- 17 of 17 side effects matched to the wording of the leaflet
Other makers of aclidinium publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.
Read the official leaflet Original on the MHRA site How we make these pages